Lymphoma

Showing NaN - NaN of 77

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lymphoma, Multiple Myeloma, Acute Myeloid Leukemia Trial in United States (TTI-622, Azacitidine, Venetoclax)

Recruiting
  • Lymphoma
  • +3 more
  • Los Angeles, California
  • +36 more
Jan 23, 2023

Leukemia, Lymphoma Trial in United States (SCRI-CAR22v2)

Recruiting
  • Leukemia
  • Lymphoma
  • SCRI-CAR22v2
  • Los Angeles, California
  • +4 more
Jan 18, 2023

Ovarian Reserve in Younger Newly Diagnosed Lymphomas

Active, not recruiting
  • Anaplastic Large Cell Lymphoma
  • +4 more
  • Laboratory Biomarker Analysis
  • Questionnaire Administration
  • Birmingham, Alabama
  • +106 more
Jan 11, 2023

Lymphoma Trial in United States (biological, drug, radiation)

Active, not recruiting
  • Lymphoma
  • rituximab
  • +5 more
  • Anchorage, Alaska
  • +258 more
Sep 23, 2022

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Lymphoma, Nonneoplastic Condition Trial in United States (bleomycin sulfate, filgrastim, ABVD regimen)

Completed
  • Lymphoma
  • Nonneoplastic Condition
  • bleomycin sulfate
  • +11 more
  • Tucson, Arizona
  • +422 more
Aug 16, 2022

Collecting and Storing Tissue From Young Patients With Cancer

Recruiting
  • Acute Lymphoblastic Leukemia
  • +13 more
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Birmingham, Alabama
  • +68 more
Aug 4, 2022

Hematopoietic and Lymphoid System Tumor, Leukemia, Lymphoma Trial in Canada, United States (procedure, biological, other)

Active, not recruiting
  • Hematopoietic and Lymphoid System Neoplasm
  • +3 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +3 more
  • Birmingham, Alabama
  • +42 more
Jul 20, 2022

Leukemia, Lymphoma Trial in Canada, United States (Patient-derived CD19- and CD22 specific CAR)

Recruiting
  • Leukemia
  • Lymphoma
  • Patient-derived CD19- and CD22 specific CAR
  • Los Angeles, California
  • +4 more
Apr 2, 2022

Breast Cancer, Lymphoma Trial in United States (Atorvastatin, Placebo)

Completed
  • Breast Cancer
  • Lymphoma
  • Los Angeles, California
  • +50 more
Dec 6, 2021

Multiple Myeloma, Lymphoma Trial in Washington, Hackensack (Ipilimumab, Nivolumab)

Active, not recruiting
  • Multiple Myeloma
  • Lymphoma
  • Washington, District of Columbia
  • +1 more
Dec 2, 2021

Lymphoma Trial in United States (ABVD, BEACOPP, radiation therapy)

Completed
  • Lymphoma
  • Saint Helena, California
  • +54 more
Nov 5, 2021

Lymphoma Trial in Washington, Baltimore (rituximab, sargramostim, EPOCH regimen)

Withdrawn
  • Lymphoma
  • rituximab
  • +7 more
  • Washington, District of Columbia
  • +1 more
Oct 19, 2021

Lymphoma Trial in United States (biological, drug, radiation, procedure)

Completed
  • Lymphoma
  • Bleomycin Sulfate
  • +11 more
  • Tucson, Arizona
  • +94 more
Jun 10, 2021

Lymphoma Trial in Canada, United States (rituximab)

Completed
  • Lymphoma
  • rituximab
  • Duarte, California
  • +7 more
Jul 30, 2020

Lymphoma Trial in Worldwide (Ibrutinib, Placebo, Rituximab)

Completed
  • Lymphoma
  • Tucson, Arizona
  • +205 more
Mar 30, 2020

Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in United States (biological, drug, procedure, radiation)

Withdrawn
  • Leukemia
  • +4 more
  • alemtuzumab
  • +6 more
  • La Jolla, California
  • +23 more
Nov 25, 2019

Lymphoma Trial in Worldwide (asparaginase, cyclophosphamide, cytarabine)

Completed
  • Lymphoma
  • Birmingham, Alabama
  • +175 more
Jul 24, 2019

Lymphoma Trial in United States (rituximab, lenalidomide)

Completed
  • Lymphoma
  • La Jolla, California
  • +78 more
Feb 6, 2017

Lymphoma Trial in United States (doxorubicin HCl, vinblastine, standard subtotal nodal irradiation)

Completed
  • Lymphoma
  • doxorubicin hydrochloride
  • +2 more
  • La Jolla, California
  • +21 more
Feb 16, 2017

Solid Tumors, Lymphoma, Multiple Myeloma Trial in Washington (CS-7017 and Bexarotene)

Terminated
  • Solid Tumors
  • +2 more
  • CS-7017 and Bexarotene
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Feb 13, 2017

Cachexia, Lymphoma, Lymphoproliferative Disorder Trial in Canada, United States (Juven, Non-Juven Supplement)

Completed
  • Cachexia
  • +3 more
  • Juven
  • Non-Juven Supplement
  • Birmingham, Alabama
  • +249 more
Dec 6, 2016

Leukemia, Lymphoma Trial in United States (filgrastim, rituximab, cyclophosphamide)

Completed
  • Leukemia
  • Lymphoma
  • filgrastim
  • +12 more
  • San Diego, California
  • +30 more
Jul 1, 2016